Duration of androgen suppression in the treatment of prostate cancer.
Bolla M; de Reijke TM; Van Tienhoven G; Van den Bergh AC; Oddens J; Poortmans PM; Gez E; Kil P; Akdas A; Soete G; Kariakine O; van der Steen-Banasik EM; Musat E; Piérart M; Mauer ME; Collette L; The New England Journal Of Medicine, 2009, vol. 360, issue 24, p 2516, ISSN 15334406. ISBN 15334406.
Full Text Resources Located for this Citation